•
Dec 31, 2018

Arrowhead Pharmaceuticals Q1 2019 Earnings Report

Total Revenue
$34.7M
Previous year: $3.51M
+887.4%
EPS
$0.13
Previous year: -$0.18
-172.2%
Gross Profit
$34.7M
Previous year: $3.51M
+887.5%
Cash and Equivalents
$190M
Previous year: $11.5M
+1545.7%
Free Cash Flow
$168M
Previous year: -$14.8M
-1230.1%
Total Assets
$341M
Previous year: $88.2M
+286.5%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals